Blood pressure variability and cardiovascular disease: systematic review and meta-analysis

SL Stevens, S Wood, C Koshiaris, K Law, P Glasziou… - bmj, 2016 - bmj.com
Objective To systematically review studies quantifying the associations of long term (clinic),
mid-term (home), and short term (ambulatory) variability in blood pressure, independent of …

The present and future of lipid testing in cardiovascular risk assessment

NMA White-Al Habeeb, V Higgins, A Wolska… - Clinical …, 2023 - academic.oup.com
Background Lipids play a central role in the pathogenesis of cardiovascular disease (CVD),
a leading cause of morbidity and mortality worldwide. Plasma lipids and lipoproteins are …

2021 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults

GJ Pearson, G Thanassoulis, TJ Anderson… - Canadian journal of …, 2021 - Elsevier
The 2021 guidelines primary panel selected clinically relevant questions and produced
updated recommendations, on the basis of important new findings that have emerged since …

Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2020 updated US Department of Veterans Affairs and US Department of …

PG O'Malley, MJ Arnold, C Kelley, L Spacek… - Annals of internal …, 2020 - acpjournals.org
Description: In June 2020, the US Department of Veterans Affairs (VA) and US Department
of Defense (DoD) released a joint update of their clinical practice guideline for managing …

High cholesterol disorders, myocardial infarction and its therapeutics

RK Upadhyay - World Journal of Cardiovascular Diseases, 2023 - scirp.org
The current review article discusses several conditions linked to high cholesterol, including
their causes, diagnoses, and treatments. Cardiovascular disease is one of the leading …

One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study

Z Sun, Y Ma, C Yu, D Sun, Y Pang, P Pei… - The Lancet Regional …, 2024 - thelancet.com
Background In non-high-risk individuals, risk-category-based atherosclerotic cardiovascular
disease (ASCVD) screening strategies may be more cost-effective than one-size-fits-all …

Worldwide dyslipidemia guidelines

MA Bartlomiejczyk, P Penson, M Banach - Current Cardiovascular Risk …, 2019 - Springer
Abstract Purpose of Review This review aims to identify common features of guidelines by
comparing and summarizing similarities between five guidelines distributed by high-profile …

[HTML][HTML] HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study

S Ohde, GA Deshpande, H Yokomichi… - Diabetes research and …, 2018 - Elsevier
Abstract [Aims] This study aims to suggest an informative interval for HbA1c in DM patients
with stable glycemic control, based on test characteristics of the HbA1C assay using the …

Feasibility of postprandial optical scattering of lipoproteins in blood as an optical marker of cardiovascular disease risk: modeling and experimental validation

A Pilvar, DW Smith, J Plutzky… - Journal of Biomedical …, 2023 - spiedigitallibrary.org
Significance Blood lipid levels (ie, triglycerides (TGs) and cholesterol) are a strong predictor
of cardiovascular disease (CVD) risk. Current methods for measuring blood lipids require …

Impact of migraine on changes in cardiovascular health profile among Hong Kong Chinese women: insights from the MECH-HK cohort study

J Liang, JJ Ma, HH Wang, Q Yang, T Ma, Q Sun… - The Journal of …, 2024 - Springer
Background Previous research has shown an association between migraine and
cardiovascular diseases (CVDs). However, limited studies have explored the progression of …